Syreon Corporation   Report issue

Founded: Vancouver Canada (1995)

Organization Overview

First Clinical Trial
2015
NCT02330146
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Syreon Corporation